These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18713478)

  • 1. Pharmaceutical industry marketing: understanding its impact on women's health.
    Sufrin CB; Ross JS
    Obstet Gynecol Surv; 2008 Sep; 63(9):585-96. PubMed ID: 18713478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gendering the migraine market: do representations of illness matter?
    Kempner J
    Soc Sci Med; 2006 Oct; 63(8):1986-97. PubMed ID: 16790309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations and advertising: controversies in the prescribing of hormone replacement therapy.
    Katz A
    Health Care Women Int; 2003 Dec; 24(10):927-39. PubMed ID: 14742130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmaceutical corporation and the 'good work' of managing women's bodies.
    Padamsee TJ
    Soc Sci Med; 2011 Apr; 72(8):1342-50. PubMed ID: 21435768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 6. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Student understanding of the relationship between the health professions and the pharmaceutical industry.
    Monaghan MS; Galt KA; Turner PD; Houghton BL; Rich EC; Markert RJ; Bergman-Evans B
    Teach Learn Med; 2003; 15(1):14-20. PubMed ID: 12632703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
    Kyle GJ; Nissen LM; Tett SE
    J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug samples: friend or foe?
    Coolidge MP
    J Drugs Dermatol; 2002 Jul; 1(1):49-52. PubMed ID: 12847754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
    Schetky DH
    Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report raises questions about drug companies advertising budgets.
    AIDS Policy Law; 1999 Aug; 14(14):1, 6. PubMed ID: 11366996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical advertising as a consumer empowerment device.
    Rubin PH
    J Biolaw Bus; 2001; 4(4):59-65. PubMed ID: 12751498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychology in the prescription era: building a firewall between marketing and science.
    Antonuccio DO; Danton WG; McClanahan TM
    Am Psychol; 2003 Dec; 58(12):1028-43. PubMed ID: 14664691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.
    Manchanda P; Honka E
    Yale J Health Policy Law Ethics; 2005; 5(2):785-822. PubMed ID: 16052900
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.